Dexcom (DXCM)

CapEx to Revenue

6.47%

Quarterly · Period ending:

DXCM logo

DXCM CapEx to Revenue

Latest reported6.47%
DXCM Quarterly CapEx/Revenue (0.00% → 6.47%)
High-resolution chart · PNG

DXCM capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
6.4736%
6.4267%
8.0899%
6.6567%
8.1324%
8.3977%
11.1899%
11.1849%
6.5817%
6.1781%
5.0749%
5.1692%
6.7715%
10.0742%
7.7895%
14.0593%
13.1428%
16.1578%
11.4867%
16.6257%
17.0055%
19.7426%
10.5818%
9.463%
12.8818%
8.1955%
9.529%
12.541%
13.9417%
14.0107%
5.2367%
8.9239%
4.2474%
8.2972%
7.9638%
7.3131%
7.034%
16.0928%
10.2804%
10.8345%
7.6475%
9.8967%
8.8685%
7.0342%
6.7597%
10.989%
5.4567%
5.3623%
6.8027%
8.2803%
4.4487%
5.1282%
5.5866%
4.7297%
4.2205%
12.5341%
12.29%
11.5452%
15.8289%
8.2502%
5.4163%
12.6358%
14.8759%
17.9441%
12.5827%
10.0367%
4.4217%
11.3652%
11.1687%
18.2272%
10.5819%
31.7188%
19.778%
56.928%
169.8298%
10.6209%
45.3071%
32.3123%
61.2032%
73.7673%
245.8977%
7,056.9882%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.